QIR Suite vs Tempus ECG-Low EF
AI Verdict
Choose QIR Suite if…
Choose QIR Suite if your clinical workflow requires comprehensive, quantitative analysis of cardiac MR and CT images for detailed diagnosis and prognosis of various cardiovascular conditions. This tool is ideal for specialists needing precise measurements of over 100 clinical parameters, including blood flow, pathological volumes, and myocardial strain, to inform complex treatment decisions.
View QIR Suite →Choose Tempus ECG-Low EF if…
Choose Tempus ECG-Low EF if you need an efficient, AI-powered screening tool to quickly identify patients aged 40 or older at risk of low left ventricular ejection fraction (LVEF ≤40%) using standard 12-lead ECG recordings. This solution is best suited for integrating into routine clinical workflows to flag patients who may require further, more definitive cardiac evaluation for heart failure risk.
View Tempus ECG-Low EF →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | QIR Suite | Tempus ECG-Low EF |
|---|---|---|
| Pricing | Contact for pricing | Unknown |
| Deployment | Locally on dedicated hardware | Integrates with current ECG platforms and electronic health records (EHRs). |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
Tempus ECG-Low EFTool B (Tempus ECG-Low EF) offers a simpler, binary output from standard ECGs and is designed for integration into existing healthcare facility workflows, making it more accessible for a broader range of clinicians. Tool A (QIR Suite), while powerful, requires dedicated hardware and provides extensive quantitative parameters from complex MR/CT images, suggesting a steeper learning curve for specialized users.
Clinical Value
TieBoth tools offer significant clinical value in different aspects of cardiovascular care. Tool A (QIR Suite) provides deep, quantitative diagnostic and prognostic insights from advanced imaging, while Tool B (Tempus ECG-Low EF) offers a valuable screening tool for early identification of low LVEF using a widely available and less invasive method.
Pricing & Value
TieNeither tool provides transparent pricing information in the structured facts, both requiring direct contact with the vendor. Without specific pricing details, it is impossible to conduct a head-to-head comparison of their value propositions.
Enterprise Readiness
Tempus ECG-Low EFTool B (Tempus ECG-Low EF) explicitly states it is HIPAA compliant and offers a Business Associate Agreement (BAA), along with integration into existing workflows. Tool A (QIR Suite) does not specify BAA or HIPAA compliance and requires local deployment on dedicated hardware, which could pose greater challenges for enterprise-scale adoption and compliance.
Innovation
TieBoth tools demonstrate significant innovation in their respective fields. Tool A (QIR Suite) pushes the boundaries of quantitative analysis in advanced cardiovascular imaging, offering over 100 clinical parameters. Tool B (Tempus ECG-Low EF) innovatively leverages common ECG data for widespread, early detection of a critical condition like low LVEF, enhancing accessibility for screening.
Support & Docs
TieNeither the provided structured facts nor general web searches yielded specific, differentiating information regarding the availability, scope, or quality of support and documentation for either tool. Therefore, a clear distinction cannot be made based on the available data.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | QIR Suite | Tempus ECG-Low EF |
|---|---|---|
| Name | QIR Suite | Tempus ECG-Low EF |
| Company | CASIS Cardiac Simulation & Imaging Software | Tempus AI |
| Description | QIR Suite is an AI-based medical imaging analysis software for cardiovascular conditions, offering quantitative evaluation of MR and CT images to support diagnosis and prognosis. | Tempus ECG-Low EF is an FDA-cleared AI software that analyzes 12-lead ECG recordings to detect signs associated with low left ventricular ejection fraction (LVEF u226440%) in patients 40 years or older at risk of heart failure. It provides a binary output to aid clinicians in further evaluation. |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI |
| Specialties | Cardiology, Radiology | Cardiology, Emergency Medicine, Internal Medicine |
| Key Features | AI-based analysis of MR and CT examinations, Detection of heart regions and pathological areas, Quantification of over 100 clinical parameters, Automatic segmentation, Blood flow/velocities quantification, Pathological volumes detection and quantification, Semi-quantification of myocardial perfusion, Strain quantification | AI-powered algorithm for ECG analysis, Detects signs of low Left Ventricular Ejection Fraction (LVEF u226440%), Analyzes resting, non-ambulatory 12-lead ECG recordings, Provides a binary output (Low LVEF Detected / Not Detected), Aids in identifying patients 40+ years at risk of heart failure, Trained on a large dataset of over 930,000 ECGs from 170,000+ patients, Intended for use in clinical diagnostic settings at healthcare facilities |
Videos
Demos, reviews, and walkthroughs featuring QIR Suite and Tempus ECG-Low EF.
Frequently Asked Questions
More Comparisons
More matchups featuring QIR Suite or Tempus ECG-Low EF
Backers
Who funded each tool's parent company.